The Role of Personalized Therapeutics in Cancer Treatment

Personalized therapeutics play a crucial role in the treatment of resistant cancers through the use of peptides derived from molecular data. These peptides, which are essential building blocks of proteins formed by amino acid sequences, can be engineered to target specific proteins involved in cancer progression. By understanding the signaling pathways and the proteins that become aberrant due to cancer evolution, therapies can be fine-tuned to mitigate tumor growth and enhance immune responses. The approach involves identifying key protein targets and tailoring peptide therapies to restore normal cellular functions and halt the progression of the disease.